| Literature DB >> 20920242 |
Bina B Kulkarni1, Patrick J Tighe, Imran Mohammed, Aaron M Yeung, Desmond G Powe, Andrew Hopkinson, Vijay A Shanmuganathan, Harminder S Dua.
Abstract
BACKGROUND: The Limbal epithelial crypt (LEC) is a solid cord of cells, approximately 120 microns long. It arises from the undersurface of interpalisade rete ridges of the limbal palisades of Vogt and extends deeper into the limbal stroma parallel or perpendicular to the palisade. There are up to 6 or 7 such LEC, variably distributed along the limbus in each human eye. Morphological and immunohistochemical studies on the limbal epithelial crypt (LEC) have demonstrated the presence of limbal stem cells in this region. The purpose of this microarray study was to characterise the transcriptional profile of the LEC and compare with other ocular surface epithelial regions to support our hypothesis that LEC preferentially harbours stem cells (SC).Entities:
Mesh:
Year: 2010 PMID: 20920242 PMCID: PMC2997017 DOI: 10.1186/1471-2164-11-526
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1Laser Microdissection (LMD) of the ocular surface epithelial regions. The composite shows steps of LMD performed on radial cut section of LEC (A, B,), limbus (C, D), cornea (E, F), conjunctiva (G, H) and LEC stroma (I, J) at 20× magnification (scale bars shown). Figure 1A is of pre LMD LEC, shown with black arrow. Figure 1 I is of LEC stroma with cells shown with white arrow. Prior to LMD, the sections were stained with RNase free Toluidine Blue. Images (A, C, E, I,) are examples of pre LMD OS epithelial region sections with outlines for laser cuts drawn around the tissue. The junctions between the OS epithelial regions were avoided as it has overlapping features of the two adjacent regions. Image (G) shows cut sections of the epithelial regions. Dividing the epithelium into multiple small pieces facilitated effective catapulting of the tissue into the collection cap. Images (B, D, F, H, J) represent examples of post LMD sections of OS epithelium following pressure catapulting of the epithelial pieces. Image J shows a misdirected piece of LEC Stroma which was not captured in the cap but settled down over the adjacent LEC Stroma (black arrow head); such tissue pieces could be recatapulted into the cap with dot LPC laser function.
Figure 2Principal Component Analysis (PCA) plot of microarray samples and genes. Left image shows PCA of LEC vs ALL samples following feature subset analysis performed on Jexpresspro software. The LEC samples are represented as green dots and rest of the samples as blue dots. LEC biological replicates are seen to cluster separately from rest of the samples indicating differences between LEC and other sample groups but similarity or reproducibility between LEC replicates. Right image shows PCA of differentially expressed genes (527) between LEC and cornea. These are clustered into four distinct coloured groups according to the density. The red group has the highest density and blue the lowest, black dots in the centre are unclustered genes.
Differentially expressed gene lists of OS epithelial regions
| Ocular Regions | Total genes | Up-reg genes | Down-reg | DAVID IDs | IPA IDs | ||
|---|---|---|---|---|---|---|---|
| LEC | 704 | 95 | 609 | 483 | 115 | 548 | 156 |
| Limbus | 463 | 169 | 294 | 294 | 79 | 355 | 106 |
| Cornea | 1649 | 1237 | 412 | 939 | 192 | 1273 | 370 |
| LEC Stroma | 329 | 113 | 216 | 234 | 52 | 266 | 70 |
| Conj | 400 | 281 | 119 | 295 | 77 | 305 | 95 |
In DAVID 2008 and Ingenuity Pathway Analysis the mapped gene IDs were analysed and the unmapped gene IDs were excluded as these were either unknown genes, ESTs, sequences or duplicated genes.
Figure 3Composite image of Gene Ontology graphs. Bar graph (A) shows statistically significant (p value ≤ 0.05) SC related GO terms in LEC, Limbus and cornea. Bar graph (B) represents statistically significant (p value ≤ 0.05) TAC and DC related GO terms in LEC, limbus and cornea. In both graphs A and B the x and y axes indicate the GO terms related to gene functions and percentages of differentially expressed upregulated genes in each category respectively. Absent bar chart for particular GO term in a region was either because of downregulated or absent gene expression.
Candidate genes expressed in SC related GO terms
| LEC | Limbus | Cornea | |||
|---|---|---|---|---|---|
| EGR1 (1.8) | ADRB2 (2.7) | - | - | ||
| LEF1 (1.3) | ZFHX3 (1.5) | - | - | ||
| GTF2A2 (4.2) | HSBP1 (1.7) | - | - | ||
| RNF14 (5.1) | POU4F1 (1.9) | - | - | ||
| SOD2 (3.5) | ID1 (1.5) | - | - | ||
| VPS72 (5.5) | SOD2 (1.6) | - | - | ||
| CDH1 (3.1) | HSBP1 (1.7) | BTG1 (3.0) | |||
| LEF1 (1.3) | - | - | CCNG1 (1.7) | ||
| - | - | - | - | PCNA (8.8) | |
| - | - | - | - | FBW7 (6.1) | |
| - | - | - | - | EIF2S2 (4.9) | |
| - | - | - | - | FZD7 (2.0) | |
| - | - | - | - | IGFBP7 (9.7) | |
| - | - | - | - | LAMA4 (2.8) | |
| - | - | - | - | NME1 (4.5) | |
| - | - | - | - | STAT3 (1.7) | |
| - | - | - | - | HES1 (2.1) | |
| - | - | LYN (1.2) | ELF4 (1.9) | ||
| - | - | PYY (2.4) | NPM1 (8.5) | ||
| - | - | ADRB2 (2.7) | RASGRF1 (6.2) | ||
| - | - | KRT5 (2.5) | |||
| - | - | USP8 (3.2) | |||
| - | - | TOB2 (1.8) | |||
| - | - | - | - | IGFBP7 (7.5) | |
| - | - | - | - | SOD2 (4.9) | |
| - | - | - | - | GADD45A (1.6) | |
| - | - | - | - | GADD45B (3.1) | |
| - | - | - | - | RUNX2 (2.4) | |
| - | - | - | - | GMNN (2.6) | |
| - | - | - | - | FOXM1 (1.9) | |
| - | - | - | - | NPM1 (8.5) | |
| - | - | - | - | ID (3.6) | |
| - | - | - | - | IGFBP7 (9.7) | |
| - | - | - | - | ING1 (2.1) | |
Candidate genes expressed in GO terms influencing the niche microenvironment, of stem/progenitor cells
| LEC | Limbus | Cornea | |||
|---|---|---|---|---|---|
| PCDH20 (1.9) | LOXL2 (2.5) | SIGLEC1 (1.7) | |||
| SIGLEC1 (1.8) | - | - | PERP (4.9) | ||
| CDH1 (3.1) | - | - | PCDH7 (3.2) | ||
| - | - | - | - | PKP2 (3.8) | |
| - | - | NUDT6 (1.7) | S100A6 (5.7) | ||
| - | - | - | - | ECGF1 (2.7) | |
| - | - | - | - | TGFA (2.6) | |
| - | - | - | - | HDGF (3.3) | |
| - | - | LYN (1.2) | BRE (3.3) | ||
| - | - | - | - | SDCBP (2.4) | |
| - | - | - | - | SIVA1 (3.8) | |
| - | - | - | - | CMTM6 (3.9) | |
| - | - | - | - | SCYE1 (7.9) | |
| - | - | - | - | CKLF (3.9) | |
| - | - | - | - | LEPR (3.5) | |
| - | - | - | - | IL6R (8.7) | |
| - | - | - | - | IL9R (4.2) | |
| PRDX4 (4.1) | PRDX5 (1.6) | SOD1 (3.9) | |||
| SOD2 (3.5) | SOD2 (1.6) | SOD2 (4.9) | |||
| - | - | - | - | PRDX1 (4.3) | |
| - | - | - | - | PRDX3 (1.9) | |
| - | - | - | - | PRDX4 (7.2) | |
| - | - | - | - | PRDX5 (3.0) | |
| - | - | - | - | MGST3 (3.7) | |
| - | - | - | - | SELS (2.0) | |
| - | - | - | - | TAP2 (2.9) | |
| - | - | - | - | GSTP1 (3.7) | |
| SERPINF1(2.4) | SERPINF1(3.1) | Humanin (4.3) | |||
| SIGLEC1 (1.8) | CD40 (1.5) | IGHG1 (5.6) | |||
| - | - | - | - | ITFG1 (4.4) | |
| - | - | - | - | CD40 (2.3) | |
| - | - | LOXL2 (2.5) | LAMA4 (2.8) | ||
Enriched canonical signaling and metabolic pathways in OS epithelial regions
| Canonical metabolic pathways | P-Value | No of genes |
|---|---|---|
| Oxidative Phosphorylation | 4.52E-17 | 29 |
| Ubiquinone biosynthesis | 8.04E-12 | 14 |
| Purine metabolism | 0.00166 | 18 |
| Pyrimidine metabolism | 0.0274 | 9 |
| Pentose Phosphate Pathway | 0.0014 | 5 |
| Oxidative Phosphorylation | 0.00795 | 7 |
| Valine, Leucine and Isoleucine Biosynthesis | 0.00851 | 2 |
| Alanine and aspartate metabolism | 0.0151 | 3 |
| Glycolysis/gluconeogenesis | 0.047 | 4 |
| Oxidative Phosphorylation | 3.48E-21 | 41 |
| Ubiquinone Biosynthesis | 2.14E-08 | 16 |
| Purine metabolism | 0.000118 | 30 |
| Alanine and Aspartate metabolism | 0.000869 | 9 |
| Glutathione metabolism | 0.00607 | 8 |
| Glycolysis/gluconeogenesis | 0.00855 | 12 |
| Lysine biosynthesis | 0.0402 | 2 |
| Citrate cycle | 0.042 | 4 |
| Pyruvate metabolism | 0.0451 | 8 |
| NRF2-mediated Oxidative Stress Response | 2.29E-05 | 16 |
| Nucleotide Excision Repair Pathway | 3.17E-05 | 7 |
| Protein Ubiquitination Pathway | 2.06E-05 | 16 |
| Estrogen Receptor Signaling | 8.79E-03 | 8 |
| Glucocorticoid Receptor Signaling | 1.81E-02 | 13 |
| NRF2-mediated Oxidative Stress Response | 2.81E-02 | 7 |
| Regulation of actin based motility by Rho | 4.51E-02 | 4 |
| NRF2 mediated Oxidative Stress Response | 2.51E-04 | 21 |
| Protein Ubiquitination Pathway | 3.09E-07 | 26 |
| Estrogen Receptor Signaling | 3.67E-04 | 15 |
| Antigen Presentation Pathway | 1.29E-03 | 7 |
| VDR/RXR Activation | 6.31E-03 | 10 |
| Glucocorticoid Receptor Signaling | 3.05E-02 | 20 |
| Nucleotide Excision repair | 2.77E-04 | 8 |
Figure 4Composite image of graphs of Real Time PCR performed on genes of interest. The real time PCR was performed on OS epithelial regions of LEC, cornea, limbus and conjunctiva comprising of three biological replicates (3 eyes) with four sets of technical replicates A, B, C & D. These were processed in triplicate. The cycle threshold (Ct) value for these samples were averaged and normalised with 18S rRNA Ct values. Significant p values between LEC and other OS regions is shown as (*),*p < 0.05, ***p < 0.001. Data are expressed as means +/- standard errors of the mean (SEM).
Figure 5Immuno-fluorescent staining for expression of stem cell molecules on ocular surface epithelium. Immunofluorescence with HES1 and FRZB1 was performed on radial cut sections of LEC (A, B, K, L), limbus (C, D, M, N) cornea (E, F, O, P) and tonsil (G, H, Q, R). Images (K, L, G, H, Q, R, I, J) are at 40× magnification, the remainder are at 20× magnification (scale bars shown). HES1 immunofluorescence co-localised with DAPI nuclear dye is shown in images (B. D, F, H,). Images (A, C, E, G) show HES1 (TRITC) staining. FRZB1 immunofluorescence co-localised with DAPI dye is shown in images (L, N, P, R). Images (K, M, O, Q,) are of FRZB1 with TRITC dye. Positive staining for HES1 and FRZB1 (B, D, F, H), (N, P, R) is seen as whitish nuclear stain, due to co-localisation of FRZB1 and HES1 (TRITC dye) and nuclear stain DAPI in the cell nuclei. FRZB1 immunofluorescence of LEC (L) is seen as yellow colouration as it intensely stained the nuclei of the basal epithelial cells in the LEC and masked the underlying DAPI staining. Positive nuclear staining of Tonsil with HES1 antibody (G, H) has speckled appearance and FRZB1 (Q, R) appears as a rim around the cell nucleus. Images (I, J) and (S, T) are negative controls for HES1 and FRZB1 antibody respectively.
Stem cell signaling pathway genes in OS epithelial regions
| Accession numbers | Gene symbols | Fold change | ||
|---|---|---|---|---|
| LEC | Limbus | Cornea | ||
| LEF1 | (1.2) | - | - | |
| CDH1 | (5.3) | - | (-5.8) | |
| BRD7 | (-4.0) | (1.8) | (4.0) | |
| CSNK1A1 | - | (4.6) | - | |
| TBL1XR1 | - | - | (1.9) | |
| FZD7 | - | - | (2.0) | |
| PORCN | - | - | (2.0) | |
| RAC1 | (-3.0) | - | (3.0) | |
| CSNK2B | (-2.6) | - | (2.6) | |
| RBX1 | (5.6) | (-5.6) | ||
| RBPJL | (-3.9) | - | (3.9) | |
| HES1 | (-1.5) | - | (2.1) | |
| RBPJ | - | - | (4.6) | |
| FBXW7 | (-6.1) | - | (6.1) | |
| SOCS6 | - | - | (3.9) | |
| LEPR | (-3.4) | (-2.2) | (3.4) | |
| LEPR | - | - | (2.3) | |
| IL9R | - | (-4.2) | (4.2) | |
| IL6R | - | (-8.7) | (8.7) | |
| STAT3 | - | - | (1.7) | |
| PKD2 | (-2.8) | - | (2.8) | |
| IL20RA | (-4.2) | - | (4.2) | |
| ID1 | (-3.6) | (1.5) | (3.6) | |
| FST | - | - | (2.4) | |
| RBX1 | (5.6) | - | (-5.6) | |
| ID1 | (-3.6) | (1.5) | (3.6) | |
| RUNX2 | (-2.4) | - | (2.4) | |
| FST | - | - | (2.4) | |
| CSNK1A1 | - | (4.5) | - | |
| IFT52 | - | (2.5) | - | |
| SAP18 | (-5.3) | (-3.7) | (6.2) | |
The differentially expressed SC signalling molecules in the OS epithelial regions were identified with KEGGS pathways and reactome. Numbers in brackets are fold change. Negative values indicate downregulated and positive values are upregulated gene expression. No values denote absence of gene expression in the region.